MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Autism Biomarker Consortium for Clinical Trials

Completed
Conditions
Autism Spectrum Disorder
First Posted Date
2016-12-19
Last Posted Date
2020-03-05
Lead Sponsor
Yale University
Target Recruit Count
399
Registration Number
NCT02996669
Locations
🇺🇸

Yale University Child Study Center, New Haven, Connecticut, United States

Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence

Early Phase 1
Completed
Conditions
Cocaine Dependence
Interventions
Other: Placebo
Dietary Supplement: N-acetylcysteine
First Posted Date
2016-12-16
Last Posted Date
2020-10-05
Lead Sponsor
Yale University
Target Recruit Count
21
Registration Number
NCT02994875
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Phase 2
Terminated
Conditions
Unresectable Intrahepatic Cholangiocarcinoma
Interventions
Drug: gemcitabine
Drug: Cisplatin
Drug: Conventional TACE (transarterial chemoembolization) with Doxorubicin/Mitomycin-C
First Posted Date
2016-12-15
Last Posted Date
2019-12-30
Lead Sponsor
Yale University
Target Recruit Count
1
Registration Number
NCT02994251
Locations
🇺🇸

Smilow Cancer Center, New Haven, Connecticut, United States

Evaluation of the Implementation and Effectiveness of IPP-HPV

Not Applicable
Completed
Conditions
HPV Vaccination
Interventions
Drug: HPV vaccine
Behavioral: Inpatient Postpartum HPV Immunization Quality Improvement Program
First Posted Date
2016-12-15
Last Posted Date
2023-01-09
Lead Sponsor
Yale University
Target Recruit Count
817
Registration Number
NCT02994290
Locations
🇺🇸

Yale New Haven Hospital, Women's Center, New Haven, Connecticut, United States

A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

Phase 1
Withdrawn
Conditions
Breast Cancer
Interventions
Radiation: Radioiodide (131I-)
First Posted Date
2016-12-09
Last Posted Date
2018-08-22
Lead Sponsor
Yale University
Registration Number
NCT02988648
Locations
🇺🇸

Smilow Cancer Center, New Haven, Connecticut, United States

Psilocybin for the Treatment of Cluster Headache

Phase 1
Completed
Conditions
Cluster Headache
Interventions
Drug: 0.0143 mg/kg Psilocybin or 1 mg Psilocybin
Drug: 0.143 mg/kg Psilocybin or 10 mg Psilocybin
Drug: Placebo
First Posted Date
2016-12-05
Last Posted Date
2023-12-15
Lead Sponsor
Yale University
Target Recruit Count
25
Registration Number
NCT02981173
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Phase 2
Active, not recruiting
Conditions
Squamous Cell Cancers of the Head and Neck
Interventions
First Posted Date
2016-12-02
Last Posted Date
2024-11-26
Lead Sponsor
Yale University
Target Recruit Count
50
Registration Number
NCT02979977
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

Betadine Pleurodesis Via Tunneled Pleural Catheters

Phase 4
Withdrawn
Conditions
Pleurodesis
Pleural Effusions, Chronic
Pleural Effusion
Malignant Pleural Effusion
Pleural Effusion Due to Congestive Heart Failure
Pleural Effusion in Conditions Classified Elsewhere
Interventions
First Posted Date
2016-11-29
Last Posted Date
2019-01-11
Lead Sponsor
Yale University
Registration Number
NCT02975921

A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Behavioral: Teens.Connect
First Posted Date
2016-11-22
Last Posted Date
2019-04-02
Lead Sponsor
Yale University
Target Recruit Count
29
Registration Number
NCT02970656
Locations
🇺🇸

Yale School of Nursing, West Haven, Connecticut, United States

Hand Grip Strength as a Marker of Frailty in Surgical Patients

Terminated
Conditions
Frailty
Interventions
Device: Obtain grip strength from a standardized gripometer
First Posted Date
2016-11-17
Last Posted Date
2020-02-10
Lead Sponsor
Yale University
Target Recruit Count
52
Registration Number
NCT02966470
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath